文献速递腹部技术与安全CT

胃癌新辅助化疗后不同方法评估肿瘤缓解的不一致性

Discordance in tumour response assessment for gastric cancer after neoadjuvant chemotherapy using different methods.
PubMed 文献 · Abdom Radiol (NY) · 2025-09-09

本研究纳入217例接受新辅助化疗的胃癌患者,在基线和治疗后CT上测量肿瘤体积、面积和厚度并计算缩减率,评估不同测量方法间的一致性及其与病理缓解和总生存的关系。结果显示不同缩减率评估间一致性为一般至中等(κ=0.26-0.50),24.88-36.87%的患者在不同方法间评估结果不一致;体积和面积缩减率预测病理缓解和总生存的准确性优于厚度缩减率。

要点

  • 不同CT测量方法评估胃癌新辅助化疗后肿瘤缓解的一致性仅为一般至中等(κ=0.26-0.50)。
  • 24.88-36.87%的患者在不同测量方法间出现治疗缓解评估不一致。
  • 体积和面积缩减率预测病理缓解和总生存优于厚度缩减率。

核心结论

  • 肿瘤缓解评估方法在不同测量间存在不一致性,体积和平面测量在预测病理缓解和总生存方面准确性优于线性测量;体积和面积缩减率均能有效对TRG 2-3患者进行总生存分层。

研究设计与样本

  • 纳入217例接受新辅助化疗的胃癌患者,在基线和治疗后CT上测量肿瘤体积、面积和厚度并计算各参数缩减率(%Δ),评估不同%Δ测量间的一致性,记录肿瘤退缩分级(TRG)和总生存(OS)数据并评价各评估方法的预测效能。

诊断标准与关键数值

  • 区分病理缓解者与非缓解者的AUC:%Δ体积为0.70,%Δ面积为0.75,%Δ厚度为0.67。
  • 预测OS的c-index:%Δ体积为0.60,%Δ面积为0.59,%Δ厚度为0.54。
  • 不同%Δ测量间的一致性为一般至中等(κ=0.26-0.50),24.88-36.87%的患者在不同方法间评估结果不一致。
  • %Δ测量与TRG之间亦观察到不一致。

临床应用与阅片要点

  • 体积和面积缩减率均能有效对TRG 2-3患者进行总生存分层,作者认为体积和平面测量预测病理缓解和OS的准确性优于线性测量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: This study aimed to evaluate whether different tumour response assessment methods yield inconsistent results following neoadjuvant chemotherapy (NACT) in patients with gastric cancer and to identify the methods most strongly associated with pathological response and prognosis.

METHODS: This study included 217 patients with gastric cancer who underwent NACT. Tumour volume, area, and thickness were measured on baseline and post-treatment computed tomography (CT) scans. Reduction rates (%Δ measurement) for each parameter were calculated, and the concordance between different %Δ measurements was assessed. Tumour regression grade (TRG) and overall survival (OS) data were recorded, and the predictive performance of the assessment methods was evaluated.

RESULTS: The concordance between different %Δ measurements ranged from fair to moderate (κ = 0.26-0.50), with 24.88-36.87% of patients showing discordant treatment response assessments across methods. The area under the curve (AUC) values for distinguishing pathological responders from non-responders were 0.70 for %Δ volume, 0.75 for %Δ area, and 0.67 for %Δ thickness. For OS prediction, the c-index values were 0.60 for %Δ volume, 0.59 for %Δ area, and 0.54 for %Δ thickness. Additionally, discrepancies were observed between %Δ measurements and TRG. Both %Δ volume and %Δ area were effective in stratifying OS in patients with TRG 2-3.

CONCLUSION: Tumour response assessment methods showed discordance across different measurements, with volumetric and planimetric measurements offering superior accuracy than linear measurements in predicting both pathological response and OS. Additionally, %Δ volume and %Δ area were effective in stratifying OS in patients with TRG 2-3.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Li J, Chen Z, Wang Y, et al. Discordance in tumour response assessment for gastric cancer after neoadjuvant chemotherapy using different methods. Abdom Radiol (NY). 2025. PMID: 40921830. doi:10.1007/s00261-025-05187-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。